vs
EVI INDUSTRIES, INC.（EVI）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
EVI INDUSTRIES, INC.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.5倍（$115.3M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 24.4%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 17.2%）
EVI Industries是一家商用洗衣、干洗及衣物护理设备的领先分销商，主要服务北美市场，客户涵盖自助洗衣店、酒店、医疗机构及多户住宅物业，同时提供设备安装、维护及售后支持服务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
EVI vs PBYI — 直观对比
营收规模更大
EVI
是对方的1.5倍
$75.5M
营收增速更快
PBYI
高出3.4%
24.4%
两年增速更快
PBYI
近两年复合增速
17.2%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $115.3M | $75.5M |
| 净利润 | $2.4M | — |
| 毛利率 | 30.8% | 69.3% |
| 营业利润率 | 3.7% | 22.7% |
| 净利率 | 2.1% | — |
| 营收同比 | 24.4% | 27.7% |
| 净利润同比 | 109.9% | — |
| 每股收益（稀释后） | $0.15 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EVIPBYI
| Q4 25 | $115.3M | $75.5M | ||
| Q3 25 | $108.3M | $54.5M | ||
| Q2 25 | $110.0M | $52.4M | ||
| Q1 25 | $93.5M | $46.0M | ||
| Q4 24 | $92.7M | $59.1M | ||
| Q3 24 | $93.6M | $80.5M | ||
| Q2 24 | $90.1M | $47.1M | ||
| Q1 24 | $84.0M | $43.8M |
净利润EVIPBYI
| Q4 25 | $2.4M | — | ||
| Q3 25 | $1.8M | $8.8M | ||
| Q2 25 | $2.1M | $5.9M | ||
| Q1 25 | $1.0M | $3.0M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $3.2M | $20.3M | ||
| Q2 24 | $2.1M | $-4.5M | ||
| Q1 24 | $956.0K | $-4.8M |
毛利率EVIPBYI
| Q4 25 | 30.8% | 69.3% | ||
| Q3 25 | 31.3% | 77.7% | ||
| Q2 25 | 30.8% | 76.5% | ||
| Q1 25 | 30.0% | 77.1% | ||
| Q4 24 | 29.7% | 76.4% | ||
| Q3 24 | 30.8% | 63.9% | ||
| Q2 24 | 30.4% | 77.4% | ||
| Q1 24 | 30.7% | 75.5% |
营业利润率EVIPBYI
| Q4 25 | 3.7% | 22.7% | ||
| Q3 25 | 3.3% | 17.6% | ||
| Q2 25 | 3.7% | 12.7% | ||
| Q1 25 | 2.4% | 8.7% | ||
| Q4 24 | 2.6% | 22.6% | ||
| Q3 24 | 5.3% | 27.4% | ||
| Q2 24 | 4.1% | -4.6% | ||
| Q1 24 | 2.9% | -5.3% |
净利率EVIPBYI
| Q4 25 | 2.1% | — | ||
| Q3 25 | 1.7% | 16.2% | ||
| Q2 25 | 1.9% | 11.2% | ||
| Q1 25 | 1.1% | 6.5% | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | 3.5% | 25.2% | ||
| Q2 24 | 2.3% | -9.6% | ||
| Q1 24 | 1.1% | -11.0% |
每股收益（稀释后）EVIPBYI
| Q4 25 | $0.15 | $0.26 | ||
| Q3 25 | $0.11 | $0.17 | ||
| Q2 25 | $0.14 | $0.12 | ||
| Q1 25 | $0.07 | $0.06 | ||
| Q4 24 | $0.07 | $0.40 | ||
| Q3 24 | $0.21 | $0.41 | ||
| Q2 24 | $0.13 | $-0.09 | ||
| Q1 24 | $0.06 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $144.0M | $130.3M |
| 总资产 | $315.6M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资EVIPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | $4.7M | $94.4M | ||
| Q2 25 | $8.9M | $96.0M | ||
| Q1 25 | $5.9M | $93.2M | ||
| Q4 24 | $3.9M | $101.0M | ||
| Q3 24 | $4.4M | $96.7M | ||
| Q2 24 | $4.6M | $96.8M | ||
| Q1 24 | $3.3M | $107.2M |
总债务EVIPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | $24.0M | $56.7M | ||
| Q4 24 | $27.9M | $68.0M | ||
| Q3 24 | $19.9M | $79.3M | ||
| Q2 24 | $12.9M | $90.7M | ||
| Q1 24 | $21.9M | $102.0M |
股东权益EVIPBYI
| Q4 25 | $144.0M | $130.3M | ||
| Q3 25 | $140.8M | $115.3M | ||
| Q2 25 | $143.5M | $104.7M | ||
| Q1 25 | $140.2M | $97.1M | ||
| Q4 24 | $138.0M | $92.1M | ||
| Q3 24 | $136.1M | $71.1M | ||
| Q2 24 | $136.6M | $48.5M | ||
| Q1 24 | $133.5M | $51.0M |
总资产EVIPBYI
| Q4 25 | $315.6M | $216.3M | ||
| Q3 25 | $321.8M | $202.9M | ||
| Q2 25 | $307.0M | $194.9M | ||
| Q1 25 | $251.8M | $196.2M | ||
| Q4 24 | $248.8M | $213.3M | ||
| Q3 24 | $245.5M | $220.7M | ||
| Q2 24 | $230.7M | $205.0M | ||
| Q1 24 | $239.3M | $214.1M |
负债/权益比EVIPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | 0.17× | 0.58× | ||
| Q4 24 | 0.20× | 0.74× | ||
| Q3 24 | 0.15× | 1.12× | ||
| Q2 24 | 0.09× | 1.87× | ||
| Q1 24 | 0.16× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.0M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 1.70× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流EVIPBYI
| Q4 25 | $4.0M | $14.4M | ||
| Q3 25 | $1.0M | $9.7M | ||
| Q2 25 | $9.9M | $14.1M | ||
| Q1 25 | $9.1M | $3.6M | ||
| Q4 24 | $2.0M | $15.6M | ||
| Q3 24 | $207.0K | $11.0M | ||
| Q2 24 | $12.4M | $1.0M | ||
| Q1 24 | $9.4M | $11.2M |
自由现金流EVIPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | $-890.0K | $9.7M | ||
| Q2 25 | $8.2M | $14.1M | ||
| Q1 25 | $8.1M | $3.6M | ||
| Q4 24 | $1.1M | $15.6M | ||
| Q3 24 | $-1.0M | $11.0M | ||
| Q2 24 | $11.2M | $1.0M | ||
| Q1 24 | $8.1M | — |
自由现金流率EVIPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | -0.8% | 17.7% | ||
| Q2 25 | 7.5% | 26.8% | ||
| Q1 25 | 8.7% | 7.7% | ||
| Q4 24 | 1.2% | 26.4% | ||
| Q3 24 | -1.1% | 13.7% | ||
| Q2 24 | 12.4% | 2.1% | ||
| Q1 24 | 9.7% | — |
资本支出强度EVIPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | 1.8% | 0.0% | ||
| Q2 25 | 1.5% | 0.0% | ||
| Q1 25 | 1.1% | 0.1% | ||
| Q4 24 | 0.9% | 0.0% | ||
| Q3 24 | 1.3% | 0.0% | ||
| Q2 24 | 1.3% | 0.0% | ||
| Q1 24 | 1.5% | 0.0% |
现金转化率EVIPBYI
| Q4 25 | 1.70× | — | ||
| Q3 25 | 0.55× | 1.10× | ||
| Q2 25 | 4.74× | 2.41× | ||
| Q1 25 | 8.79× | 1.21× | ||
| Q4 24 | 1.74× | — | ||
| Q3 24 | 0.06× | 0.54× | ||
| Q2 24 | 5.99× | — | ||
| Q1 24 | 9.85× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
